Pubblicazioni

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors

2020 - BMC CANCER
Miele, Evelina; Abballe, Luana; SPINELLI, GIAN PAOLO; BESHARAT, ZEIN MERSINI; Catanzaro, Giuseppina; Chiacchiarini, Martina; Vacca, Alessandra; PO, AGNESE; Capalbo, Carlo; Ferretti, Elisabetta

Exploring treatment with Ribociclib alone or in sequence/combination with Everolimus in ER+HER2−Rb wild-type and knock-down in breast cancer cell lines

2020 - BMC CANCER
Marinelli, O.; Romagnoli, E.; Maggi, F.; Nabissi, M.; Amantini, C.; Morelli, M. B.; Santoni, M.; Battelli, N.; Santoni, G.

National Italian Delphi panel consensus: Which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

2020 - BMC CANCER
Lussana, F.; Minetto, P.; Ferrara, F.; Chiaretti, S.; Specchia, G.; Bassan, R.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma